Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical vancomycin vs placebo to prevent sinonasal polyposis recurrence after FESS
IRCT201312299014N20Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Sep 2014
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in chronic rhinosinusitis with nasal polyps (CRSwNP) comparing Topical vancomycin with Placebo (2 arms). Primary endpoint: Recurrence of sinonasal polyposis. Started Sep 2014; status: completed.
02
Drugs
vancomycin
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT201312299014N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201312299014N20.